Stem Cells calls for papers / meetings & conferences

Call for Papers: Stem Cells Forum: Working Towards Clinical Application

Wednesday, 03 October 2012 09:00 - 17:00

London, United Kingdom

The Deadline for abstract submissions for oral presentation is July 10th 2012

This event is discussion forum, focused on clinical applications of stem cell therapy. The aim is to offer participants a chance to explore aspects with the experts during round table and one-to one discussions.

Meeting Chair: Dr Glyn Stacey, UK Stem Cell Bank, Division of Cell Biology and Imaging.

Contact Details

Meeting Secretariat Email: astrid.englezou@euroscicon.com

General Enquires Email: enquiries@euroscicon.com

Call for Abstracts: 12th International Symposium on Myelodysplastic Syndromes

May 8-11, 2013 Berlin, Germany

Abstract submission deadline: February 6, 2013

The scientific program is designed to meet the aims of The MDS Foundation, which are “to provide an ongoing exchange of information relating to MDS and provides patients with referrals to Centers of Excellence, contact names for available clinical trials, sharing of new research and treatment options between physicians, and extension of educational support to both physicians and patients." The format will include plenary sessions (including a nursing symposium), debates, case-based discussion, topical workshops, oral and poster presentations.

This 12th symposium will again promote the clinical application of existing knowledge and the acquisition of new knowledge by bringing together clinicians, scientists and educators from around the world who deal with MDS.

Clinical Management: General
Diagnosis (including morphology, flow cytometry, molecular)
Epidemiology (including demographics, quality of life, co-morbidity)
Pathogenesis (including molecular, immunological, cellular, animal models, other)
Childhood MDS
Prognostic Factors and Models
Supportive Care including Iron Chelation Therapy
Stem Cell Transplantation
Therapy (including high-risk MDS, low-risk MDS, other)
Other

Call for Papers: Joint Meeting of the American Pancreatic Association and the International Association of Pancreatology

October 31 - November 3, 2012 Miami, Florida

Deadline: June 25 at Midnight CST

The 2012 Annual Meeting of the American Pancreatic Association (APA) to be held jointly with the International Association of Pancreatology (IAP) will take place at the Eden Roc Renaissance in Miami Beach FL from Oct 31-Nov 3. The meeting will include several mini-symposia in addition to abstract driven sessions including a symposia on Pancreatic Stem Cells and Stellate Cells (organized by Minoti Apte and Diane Simeone on Saturday Nov 3) and a consensus conference open to all participants to update the 2002 IAP Evidence-Based Guidelines on the Management of Acute Pancreatitis (on Wednesday October 31).

Abstracts must be received no later than June 25th to be considered for presentation at the meeting. Abstracts can be submitted electronically. The submission fee for each abstract is $60 and is required for each abstract, whether published or not. When you have submitted your abstract electronically, you will be able to pay the abstract fee with a credit card through PayPal. Alternatively, you may also mail a check, payable to American Pancreatic Association, for each abstract submitted.

Call for Abstracts: Aging and Diseases of Aging

22 Oct 2012 through 27 Oct 2012 Tokyo, Japan

LANGUAGE NOTE: This meeting will be conducted in English.

On and before June 21, 2012, the cost is $50.00, which is deducted from your registration fee when you register for this meeting.

After June 21, 2012, there is an additional $50.00 fee, which is NOT deducted from the registration fee.

You may submit your abstract on the conference web site until July 25, 2012.

(After this date you will need to contact our office about submitting an abstract.)

Age-related diseases and disabilities, such as cancer, diabetes, and neuronal degeneration, pose an ever increasing social and economic burden worldwide. Fortunately, the last decades have witnessed dramatic progress in our understanding of the aging process. Genetic studies in particular have helped elucidate some of the molecular pathways that regulate the aging and offered new insights into the treatment of age-related diseases. However, there is still much to be learned and further progress in addressing the unique challenges of the aging population will require new insights and novel approaches. In order to accelerate the discovery process, this Keystone Symposia meeting will cover essential aspects of the aging processes, including cell signaling pathways, DNA stability, protein homeostasis, stem cells and cellular senescence. Each plenary session will emphasize innovative findings from a variety of models in basic research areas and link them to age-related disease and frailty. The ultimate goal is to provide an opportunity for attendees to communicate and promote an integrated understanding of aging and age-related diseases. The program for this meeting is highly likely to attract a wide variety of investigators, many of whom might not otherwise interact.

Keystone Symposia
Phone: +1 (800) 253-0685 or +1 (970) 262-1230
Fax: +1 (970) 262-1525
info@keystonesymposia.org

Call for Abstracts: 12th International Conference on Cancer-Induced Bone Disease

15 to 17 November, 2012 Lyon, France

Abstract Submission Deadline: 2 July 2012

Call for Late-Breaking Abstracts: 1 August 2012

The International Meeting on Cancer-Induced Bone Disease is among the most exciting international occasions for the exchange of the latest scientific discoveries. They are designed to allow attendees to enhance their knowledge of diseases of the skeleton, basic bone biology, mineral metabolism, and their correlation to oncology.

Discussions on the latest advances in innovative treatments and cutting-edge practices await you at the 2012 event. The conference takes place 15-17 November 2012 in Lyon, France. The world’s leading scientists and researchers will be on-hand to share their expertise in bone metastases and bone and cancer cell biology.

Learning Objectives
The importance of both the physical and cellular bone microenvironment and the hematopoietic stem cell niche in supporting the growth of metastatic cancer cells
The role of cancer stem cells and hematopoietic stem cells in the metastatic process
The current state of the field of genomics and proteomics as applied to bone metastasis
The efficacy of new therapeutic agents and imaging techniques for bone cancers and bone metastasis
The consequences of tumor cells on the skeleton
Understanding of the mechanisms of therapy resistance

IBMS and CABS meetings are premier international scientific events that provide an international forum to present and discuss current basic and clinical science in the rapidly advancing field of skeletal complications of cancer.

International Bone and Mineral Society (IBMS)
401 N Michigan Ave Chicago, Suite 2200, IL 60611 USA
Phone: +1 312-321-5113 | Fax: +1 312-673-6934 | Email: info@ibmsonline.org

Call for Papers: IEEE-EMBS Micro- and Nanoengineering in Medicine Conference (MNMC 2012)

Translating Technology from the Bench to the Bedside

December 3-7, 2012 The Westin Maui Resort and Spa, Ka’anapali, Hawaii

Call for Papers Opened: July 1, 2012

Call for Papers Site Closed: August 1, 2012

Notification of Acceptance: September 1, 2012

Various biomedical grand challenges facing our society and the world can be addressed by interfacing biology and medicine with micro- and nanoscale technologies. These technologies hold great potential to impact early diagnosis, therapeutics, and management of disease. IEEE EMBS is sponsoring the first Conference on Micro- and Nanoengineering in Medicine to foster interaction between scientists, engineers and medical researchers in the context of real-world medical needs and issues. The Conference will promote vigorous and open dialogue towards the development of cutting edge technologies for faster, more quantitative, and less expensive biomedical solutions using advances in micro and nanotechnology.

Keywords for Papers

Global health
Microfluidics
Nanotechnology
Microfabrication
Stem cells
Regenerative medicine
Tissue engineering
Diagnostics
Bionanotechnology
BioMEMS
Point-of-care
Nanomedicine
Lab-on-Chip

Call for Abstracts: 24th Annual Fanconi Anemia Research Fund Scientific Symposium

September 27 – 30, 2012 Denver, Colorado

Session topics may include:

Bone marrow failure and transplantation
Gene therapy and stem cell expansion
Functions of FA proteins
Role of environmental and endogenous mutagens
Small molecule development and therapeutics
Other experimental therapies
Squamous cell carcinoma and HPV
Other cancers in FA
Molecular pathogenesis and control of hematopoietic and epithelial neoplasms
Pathophysiology and treatment of endocrinopathies

Abstracts may be submitted from May 29 to June 28, 2012 at www.fanconi.org. The submission site will open at 9:00 am Pacific Time on May 29 and close at 9:00 am Pacific Time on June 28. The Fund’s abstract review committee will select abstracts for oral and poster presentations based on scientific merit. Please see complete abstract submission guidelines.

Note: There will be no late-breaking abstracts submission period.

Attendance: Presenters are expected to attend for the duration of the symposium, including the closing Symposium Town Hall: An Interactive Discussion about FA Research on September 30.

Call for Abstracts: Vasculata 2012

July 25-28, 2012 Nashville, Tennessee

Abstracts will be accepted for poster presentation in the following categories:

Angiogenesis
Atherosclerosis
Developmental Vascular Biology
Endothelium
Genetics and Vascular Disease
Inflammation
New Approaches (nanotechnology, imaging)
Stem Cells in Vascular Biology
Tissue Engineering and Regenerative Medicine
Vascular Cell Biology
Vascular Biology- Other

Presenters will be provided with a 6 foot high by 6 foot wide bulletin board.

For more information, please read the policies and procedures at www.navbo.info/VasculataRules2012.pdf

Deadline for submission of abstracts is June 1 at 5:00pm EST

Call for Abstracts: Germline - Immortality Through Totipotency

European Molecular Biology Laboratory Heidelberg, Germany

Saturday 13 October - Tuesday 16 October 2012

Abstract submission deadline is Thursday 9 August 2012.

We only accept online abstract submission.

Why You Should Attend

Summary
What does immortality mean at the molecular, cellular, transgenerational and evolutionary level?

Most organisms have a defined lifespan, however life of a species continues and evolves via germline from generation to generation. Recent studies show that tissue stem cells share molecular and developmental signatures with the germline and that even fully differentiated, postmitotic cells can be reprogrammed to regain totipotency.

This EMBO | EMBL Symposium will go beyond a description of the phenomena involving stem cell behaviour, programming and reprogramming. It will bring together researchers from different disciplines, who will address fundamental questions of totipotency as they relate to evolution, development and tissue specialization.

Questions to be discussed include:

how a need for germline specification arose during the evolution of multicellularity from single cells to colonies with specialized cell types;

how the fertilized egg cell loses totipotency during formation of a multicelluar organism;

how chromatin-based mechanisms influence totipotency both at the cellular and transgenerational level; and

how the decision toward meiosis is achieved and regulated.

Topics

From single cells to multicellularity

Keeping it all together: chromosomes and chromatin

Programming and reprogramming

Conservative vs progressive divisions (mitosis and meiosis)

Context matters

EMBL Course and Conference Office
European Molecular Biology Laboratory
Meyerhofstraße 1
69117 Heidelberg
Germany

Tel: +49 6221 387 8797
Fax: +49 6221 387 8158

Call for Abstracts: Temporomandibular Joint Disorder Bioengineering Conference

We are inviting you to submit an abstract to the TMJ Bioengineering Conference (TMJ3), which will take place on Thursday September 20 through Saturday September 22, 2012, in Pittsburgh, Pennsylvania.

The Program Committee has selected the following thematic areas for this year’s Conference:

Bone, cartilage, and stem cell biology
Cell, tissue, and joint biomechanics
Biomaterials for bone and cartilage tissue engineering
Diagnosis and imaging of TMDs
Treatment and surgery of the TMJ
TMJ Pain and inflammation

Abstract Submission Deadline: May 30, 2012

Notification of Acceptance: June 23, 2012

We suggest that you please encourage your young investigators to submit abstracts on new and novel studies. Those abstracts that are based on high risk/high payoff translational research will be given priority to be accepted and presented. Please make plans and register early to join us as the attendance at the Conference will be limited to 100 participants to facilitate more discussion.

Instructions for submission and the format of the abstract can be found at the Conference website: http://tmjconference.org